Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Value-Based Care in Cardiometabolic Health Dec 2012, Vol 1, No 3
Cardiometabolic Health
Control of 4 Risk Factors Would Slash CHD Rate in Diabetes by Half
Wayne Kuznar
Read More
FDA Approvals
GLP-1 Agonism Holds Promise for Preventing Macrovascular Disease in Type 2 Diabetes
Wayne Kuznar
Read More
FDA Approvals
CVD Pipeline: Novel Approaches to Modifying Lipids/Lipoproteins
Mary Mosley
Read More
Belly Fat Triples CV and All-Cause Mortality, Even with Normal Weight
Mary Mosley
Read More
1
2
3
Page 3 of 3
Results 21 - 24 of 24
